Tanning facility use: Are we exceeding Food and Drug Administration limits?

Journal of the American Academy of Dermatology

Volumn 49, Issue 4, 2003, Pages 655-661

  Hornung, Robin L ^e   Magee, Kristin H ^a   Lee, Willie J ^b   Hansen, Lori A ^c   Hsieh, Yi Ching ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Radiation Protection Inc   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZATION; SKIN PIGMENTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; UNITED STATES;

EID: 0141867884     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)01586-X     Document Type: Article

References (44)

1. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
2. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21 st century. J Am Acad Dermatol 1996;34:839-47.
3. Centers for Disease Control and Prevention. Injuries associated with ultraviolet tanning devices: Wisconsin. MMWR Morb Mortal Wkly Rep 1989;38:333-5.
4. Walters BL, Kelley TM. Commercial tanning facilities: a new source of eye injury. Am J Emerg Med 1987;5:386-9.
5. Council on Scientific Affairs. Harmful effects of ultraviolet radiation. JAMA 1989;262:380-4.
6. Epstein JH. Suntan salons and the American skin. South Med J 1981;74:837-40.
7. Woman dies from burns. Winston-Salem Journal 1989 May 28.
8. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995;32:53-62.
9. Lowe NJ, Meyers DP, Wieder JM, Luftman D, Borget T, Lehman MD, et al. Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J Invest Dermatol 1995;105:739-43.
10. Ham WT Jr, Ruffolo JJ Jr, Mueller HA, Guerry D 3rd. The nature of retinal radiation damage: dependence on wavelength, power level and exposure time. Vision Res 1980;20:1105-11.
11. Hollows F, Moran D. Cataract: the ultraviolet risk factor. Lancet 1981;2:1249-50.
12. Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 1994;58:809-13.
13. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990;131:232-43.
14. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N, Brandt L, et al. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 1994;140:691-9.
15. Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 2000;82:1593-9.
16. Dinehart SM, Dodge R, Stanley WE, Franks HH, Pollack SV. Basal cell carcinoma treated with Mohs surgery: a comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992;18:560-6.
17. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002;94:224-6.
18. Looking Fit Tanning Fact Book 2002/2003. Phoenix: Virgo Publishing; 2002.
19. Miller SA, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem Photobiol 1998;68:63-70.
20. Spencer JM, Amonette R. Tanning beds and skin cancer: artificial sun + Old Sol = real risk. Clin Dermatol 1998;16:487-501.
21. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA Follow-Up Study. N Engl J Med 1997;336:1041-5.
22. Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst 1998;90:1278-84.
23. Gange RW, Blackett AD, Matzinger EA, Sutherland BM, Kochevar IE. Comparative protection efficiency of UVA- and UVB-induced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J Invest Dermatol 1985;85:362-4.
24. Devgun MS, Johnson BE, Paterson CR. Tanning, protection against sunburn and vitamin D formation with a UV-A "sunbed." Br J Dermatol 1982;107:275-84.
25. Department of Health and Human Services (US), Food and Drug Administration. Sunlamp products: performance standard; final rule (21 CFR 1040). Fed Reg 1985;50:36548-52.
26. Department of Health and Human Services (US), Food and Drug Administration. Letter from the Director, Office of Compliance, Center for Devices and Radiological Health, to all manufacturers, importers, and potential manufacturers of sunlamp products. Subject: policy on maximum timer interval and exposure schedule for sunlamp products, Aug 1986.
27. State of North Carolina: Tanning facilities. Title 15A, NCAC Chapter 11, Section 1400. Jan 4, 1990.
28. Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, Belch GE. Promotion of frequent tanning sessions by indoor tanning facilities: two studies. J Am Acad Dermatol 2002;46:700-5.
29. Fairchild AL, Gemson DH. Safety information provided to customers of New York City suntanning salons. Am J Prev Med 1992;8:381-3.
30. Oliphant JA, Forster JL, McBride CM. The use of commercial tanning facilities by suburban Minnesota adolescents. Am J Public Health 1994;84:476-8.
31. Bruyneel-Rapp F, Dorsey SB, Guin JD. The tanning salon: an area survey of equipment, procedures, and practices. J Am Acad Dermatol 1988;18:1030-8.
32. Beyth R, Hunnicutt M, Alguire PC. Tanning salons: an area survey of proprietors' knowledge of risks and precautions. J Am Acad Dermatol 1991;24:277-82.
33. Lillquist PP, Baptiste MS, Witzigman MA, Nasca PC. A population-based survey of sun lamp and tanning parlor use in New York State, 1990. J Am Acad Dermatol 1994;31:510-2.
34. Lucci A, Citro HW, Wilson L. Assessment of knowledge of melanoma risk factors, prevention, and detection principles in Texas teenagers. J Surg Res 2001;97:179-83.
35. Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986;122:537-45.
36. Diffey BL. Use of UV-A sunbeds for cosmetic tanning. Br J Dermatol 1986;115:67-76.
37. Whitmore SE, Morison WL, Potten CS, Chadwick C. Tanning salon exposure and molecular alterations. J Am Acad Dermatol 2001;44:775-80.
38. Fleischer AB Jr, Fleischer AB. North Carolina tanning operators: hazard on the horizon? J Am Acad Dermatol 1992;27:199-203.
39. United States Department of Agriculture, UVB Monitoring and Research Program: 2002. Available from: URL: http://uvb.nrel. colostate.edu/uvb_intercomparison.
40. Lim HW,Cooper K. The health impact of solar radiation and prevention strategies: report of the Environment Council, American Academy of Dermatology. J Am Acad Dermatol 1999;41:81-99.
41. McGinley J, Martin CJ, MacKie RM. Sunbeds in current use in Scotland: a survey of their output and patterns of use. Br J Dermatol 1998;139:428-38.
42. The state of regulations. Tanning Trends Magazine 2001;November.
43. Fleischer AB Jr, Lee WJ, Adams DP, Zanolli MD. Tanning facility compliance with state and federal regulations in North Carolina: a poor performance. J Am Acad Dermatol 1993;28:212-7.
44. Department of Health and Human Services (US), Food and Drug Administration. Medical devices; sunlamp products performance standard; request for comments and information, proposed rule (21 CFR 1020). Fed Reg 1999;64:6288-90.